We are live on ! Find out more
VEA

Virtus ETF Advisers Portfolio holdings

AUM $215M
1-Year Est. Return 53.68%
This Fund
S&P 500
This Quarter Est. Return
+4.68%
1 Year Est. Return
+53.68%
3 Year Est. Return
+121.72%
5 Year Est. Return
+144.54%
10 Year Est. Return
+633.35%
AUM
$223M
AUM Growth
-$41.4M
Cap. Flow
-$38.1M
Cap. Flow %
-17.06%
Top 10 Hldgs %
11%
Holding
420
New
44
Increased
50
Reduced
231
Closed
47

Top Buys

Rank Stock Value
1
MOS icon
The Mosaic Company
MOS
+$2.06M
2
PBR icon
Petrobras
PBR
+$2M
3
VALE icon
Vale
VALE
+$1.96M
4
CQP icon
Cheniere Energy
CQP
+$1.94M
5
STR
Sitio Royalties
STR
+$1.94M

Top Sells

Rank Stock Value
1
BCC icon
Boise Cascade
BCC
+$2.62M
2
EXR icon
Extra Space Storage
EXR
+$2.49M
3
CNQ icon
Canadian Natural Resources
CNQ
+$2.46M
4
IMO icon
Imperial Oil
IMO
+$2.45M
5
AVNT icon
Avient
AVNT
+$2.42M

Sector Composition

Rank Sector Weight
1 Materials 20.16%
2 Real Estate 20.02%
3 Healthcare 16.51%
4 Energy 10.55%
5 Utilities 10.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EVLO
351
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
$71K 0.03%
1,051
-62
-6% -$5.16K
CUE icon
352
Cue Biopharma
CUE
$118M
$70K 0.03%
476
-28
-6% -$5.94K
ORIC icon
353
Oric Pharmaceuticals
ORIC
$1.17B
$69K 0.03%
12,914
-763
-6% -$6.87K
CTMX icon
354
CytomX Therapeutics
CTMX
$690M
$68K 0.03%
25,634
-1,516
-6% -$5.82K
NVAX icon
355
Novavax
NVAX
$1.21B
$68K 0.03%
921
-54
-6% -$4.82K
RUBY
356
DELISTED
Rubius Therapeutics, Inc
RUBY
$66K 0.03%
12,052
-721
-6% -$4.58K
ZYME icon
357
Zymeworks
ZYME
$1.62B
$64K 0.03%
9,749
-575
-6% -$5.13K
RNAC icon
358
Cartesian Therapeutics
RNAC
$218M
$61K 0.03%
1,641
-97
-6% -$6.07K
RXRX icon
359
Recursion Pharmaceuticals
RXRX
$1.58B
$60K 0.03%
8,321
-500
-6% -$5.31K
SRNE
360
DELISTED
Sorrento Therapeutics, Inc.
SRNE
$59K 0.03%
25,427
-1,501
-6% -$4.68K
DTIL icon
361
Precision BioSciences
DTIL
$178M
$58K 0.03%
632
-37
-6% -$5.03K
GRCL
362
DELISTED
Gracell Biotechnologies Inc. American Depositary Shares
GRCL
$58K 0.03%
24,728
-1,469
-6% -$5.01K
GRTS
363
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
$56K 0.03%
13,538
-808
-6% -$4.28K
NBP
364
NovaBridge Biosciences American Depositary Shares
NBP
$186M
$51K 0.02%
3,136
-189
-6% -$4.84K
AKBA icon
365
Akebia Therapeutics
AKBA
$338M
$47K 0.02%
65,149
-3,866
-6% -$8.27K
BBIO icon
366
BridgeBio Pharma
BBIO
$16.4B
$41K 0.02%
4,057
-247
-6% -$2.54K
LITS
367
Lite Strategy Inc
LITS
$32.4M
$39K 0.02%
3,231
-191
-6% -$7.5K
BCAB icon
368
BioAtla
BCAB
$5.34M
$37K 0.02%
150
-8
-5% -$3.35K
ANNX icon
369
Annexon
ANNX
$796M
$31K 0.01%
11,398
-680
-6% -$4.18K
ALGS icon
370
Aligos Therapeutics
ALGS
$26.3M
$29K 0.01%
537
-31
-5% -$2.48K
KOD icon
371
Kodiak Sciences
KOD
$2.5B
$15K 0.01%
1,902
-111
-6% -$4.33K
ALLK
372
DELISTED
Allakos
ALLK
$11K ﹤0.01%
1,902
-112
-6% -$724
AES icon
373
AES
AES
$10.6B
– –
-83,155
Closed -$2.02M
AIV
374
Aimco
AIV
$377M
– –
-286,482
Closed -$2.21M
APD icon
375
Air Products & Chemicals
APD
$65.5B
– –
-7,619
Closed -$2.32M
13 14
15
16 17

Similar funds

NCM
NEXTBio Capital Management Menlo Park, California $215M AUM
SSA
SSA Swiss Advisors Zurich $216M AUM 17.86% 1-Year Est. Return
LIWM
Long Island Wealth Management Melville, New York $216M AUM 14.59% 1-Year Est. Return
VFG
V2 Financial group Naperville, Illinois $215M AUM 15.18% 1-Year Est. Return
IAM
Impala Asset Management Palm Beach, Florida $215M AUM 86.77% 1-Year Est. Return
1M
1248 Management Kansas City, Missouri $216M AUM 12.29% 1-Year Est. Return
RC
Roubaix Capital Denver, Colorado $214M AUM 32.43% 1-Year Est. Return
TSS
Taylor Securities Services Harrisburg, Pennsylvania $214M AUM

Virtus ETF Advisers's Q1 2022 Portfolio in Review

As of Q1 2022, Virtus ETF Advisers held 420 positions worth $223M, down 16% from $265M the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Virtus ETF Advisers withdrew a net $38.1M in Q1 2022, closing 47 positions and reducing 231 holdings. Its most notable exit was Boise Cascade, an estimated $2.62M position sold in full.

By sector, the portfolio is most concentrated in Materials at 20% of assets, up from 14% a quarter earlier, followed by Real Estate and Healthcare.

Against the trend, Virtus ETF Advisers opened a new position in The Mosaic Company worth $2.75M.

  • Virtus ETF Advisers's largest Q1 2022 buy was The Mosaic Company: 41,283 shares worth $2.75M.
  • Virtus ETF Advisers added most to Agnico Eagle Mines in Q1 2022, an estimated $1.28M increase.
  • Virtus ETF Advisers's biggest Q1 2022 reduction was Gold Fields, cutting an estimated $1.09M.
  • Virtus ETF Advisers fully exited Boise Cascade in Q1 2022, selling an estimated $2.62M.
  • Virtus ETF Advisers's ten largest holdings make up 11% of its $223M portfolio in Q1 2022.
  • Virtus ETF Advisers opened 44 new positions and closed 47 in Q1 2022.
  • Virtus ETF Advisers's portfolio value fell 16% quarter-over-quarter to $223M.

Based on Virtus ETF Advisers's 13F filing for Q1 2022, filed 16 May 2022.